Clinical Trial on Agitation in Alzheimer's Dementia
Part of paid clinical trials in Maitland, Florida.
- Sponsor
- IGC Pharma, LLC
- Study ID
- NCT05543681
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Aggression
- Agitation,Psychomotor
- Alzheimer Disease
- Care Giving Burden
- NPS
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- IGC-AD1-Active — DRUGA non-sterile solution for oral administration.
- IGC-AD1-Placebo — DRUGA non-sterile solution for oral administration similar in color and texture to the Active.
Study Details
The purpose of this study is to assess the efficacy of the oral medication IGC-AD1, a THC-based (Delta-9-Tetrahydrocannabinol) formulation administered twice a day on Agitation in patients with mild to severe dementia from Alzheimer's.
Key Dates
- Start date
- Oct 11, 2022
- Status verified
- May 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 164 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Active Comparator: IGC-AD1ActiveIGC-AD1-Active, oral solution with two APIs (THC and melatonin).
- Placebo Comparator: Placebo Comparator: IGC-AD1 PlaceboIGC-AD1-Placebo, oral solution similar to Active in color, taste, and texture, with excipients but without APIs.
Primary Outcome Measure
Agitation [ Time Frame: Baseline to week six ]
Central Contacts
- Evelyn Gutiérrez+13013394270
- Margarita Venegas
Locations (23)
Find similar trials in Maitland, FL
By condition
By specialty
Related Studies
- F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)Enrolling By Invitation · Washington University School of Medicine · St Louis, Missouri
- F 18 T807 Tau PET Imaging of Alzheimer's DiseaseRecruiting · Tammie L. S. Benzinger, MD, PhD · St Louis, Missouri
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseasePHASE4 · Recruiting · University of Texas at Austin · Austin, Texas